SEC Form 10-K filed by Eastman Kodak Company Common New
$KODK
Industrial Machinery/Components
Consumer Discretionary
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
10-K - EASTMAN KODAK CO (0000031235) (Filer)
8-K - EASTMAN KODAK CO (0000031235) (Filer)
8-K - EASTMAN KODAK CO (0000031235) (Filer)
Company Achieved Revenue Growth for the Quarter and the Full Year Company Achieved Significant Full-Year Improvements in Gross Profit and Operational EBITDA Year-End Cash Balance of $337 Million, an Increase of $136 Million for the Year Key Print and AM&C Businesses Achieved Full-Year Increases in Operational EBITDA Eastman Kodak Company (NYSE:KODK) today reported financial results for the fourth quarter and full year 2025. Fourth quarter 2025 highlights include: Consolidated revenues of $290 million, compared with $266 million for Q4 2024, an increase of $24 million or 9 percent Advanced Materials & Chemicals (AM&C) revenues were $85 million, compared with $68 million for Q4
Kodak will host the Fourth-Quarter and Full-Year 2025 Earnings call on Thursday, March 12, 2026, at 5:00 pm EDT. Executive Chairman and Chief Executive Officer James Continenza and Chief Financial Officer David Bullwinkle will host a conference call with financial analysts and investors to discuss the financial results. GENERAL EVENT DETAILS Title: Eastman Kodak Q4 and Full-Year 2025 Earnings Conference Call Date: 03/12/2026 Start time: 5:00pm EDT PARTICIPANT WEBCAST LINK: This link should be distributed to anyone who would like to view the live webcast. https://edge.media-server.com/mmc/p/i8tctroh View source version on businesswire.com: https://www.businesswire.com/news/home/20
New U.S.-Manufactured PBS and WFI Offerings Deliver Reliable, High-Quality Supply for Labs, Biopharma Industry and CDMOs Eastman Kodak Company (NYSE:KODK) today announced the expansion of its pharmaceuticals portfolio with four new regulated products: KODAK Phosphate Buffered Saline (PBS) 1X in low endotoxin and RNase/DNase/Protease-free formulations, and KODAK Water for Injection (WFI) in standard and RNase/DNase/Protease-free formulations. All are immediately available for order by U.S. research laboratories, biopharma developers, and contract development and manufacturing organizations (CDMOs). The two new PBS formulations join a standard PBS 1X already shipping, while the WFI produc
4 - EASTMAN KODAK CO (0000031235) (Issuer)
4 - EASTMAN KODAK CO (0000031235) (Issuer)
4 - EASTMAN KODAK CO (0000031235) (Issuer)
4 - EASTMAN KODAK CO (0000031235) (Issuer)
4 - EASTMAN KODAK CO (0000031235) (Issuer)
4 - EASTMAN KODAK CO (0000031235) (Issuer)
Company Achieved Revenue Growth for the Quarter and the Full Year Company Achieved Significant Full-Year Improvements in Gross Profit and Operational EBITDA Year-End Cash Balance of $337 Million, an Increase of $136 Million for the Year Key Print and AM&C Businesses Achieved Full-Year Increases in Operational EBITDA Eastman Kodak Company (NYSE:KODK) today reported financial results for the fourth quarter and full year 2025. Fourth quarter 2025 highlights include: Consolidated revenues of $290 million, compared with $266 million for Q4 2024, an increase of $24 million or 9 percent Advanced Materials & Chemicals (AM&C) revenues were $85 million, compared with $68 million for Q4
Kodak will host the Fourth-Quarter and Full-Year 2025 Earnings call on Thursday, March 12, 2026, at 5:00 pm EDT. Executive Chairman and Chief Executive Officer James Continenza and Chief Financial Officer David Bullwinkle will host a conference call with financial analysts and investors to discuss the financial results. GENERAL EVENT DETAILS Title: Eastman Kodak Q4 and Full-Year 2025 Earnings Conference Call Date: 03/12/2026 Start time: 5:00pm EDT PARTICIPANT WEBCAST LINK: This link should be distributed to anyone who would like to view the live webcast. https://edge.media-server.com/mmc/p/i8tctroh View source version on businesswire.com: https://www.businesswire.com/news/home/20
Company Achieved Significant Improvements in Gross Profit, Operational EBITDA and Cash Balance Pension Reversion Transaction Proceeding on Schedule with Expected Proceeds Increasing from $500 Million to $600 Million Previously Disclosed Going Concern Conditions Have Been Fully Resolved Eastman Kodak Company (NYSE:KODK) today reported financial results for the third quarter 2025. Third quarter 2025 highlights include: Consolidated revenues of $269 million, compared with $261 million for Q3 2024, an increase of $8 million or 3 percent Advanced Materials & Chemicals (AM&C) revenues were $82 million, compared with $71 million for Q3 2024, an increase of $11 million or 15 percent Print
Appoints Becky Roof as Interim Chief Financial Officer (CFO) and Engages AlixPartners to Accelerate Implementation of Special Committee Recommendations Faraday Future Intelligent Electric Inc. ("FF") (NASDAQ:FFIE), a California-based global shared intelligent electric mobility ecosystem company, today announced the appointment of Becky Roof as interim Chief Financial Officer, and the engagement of AlixPartners, LLP. Effective immediately, Ms. Roof will replace Walter J. ("Chuck") McBride, who has stepped down from his position for health reasons. Sue Swenson, Executive Chairperson of Faraday Future, said, "As we push to accelerate our remediation plan and strengthen the Company's financ
SC 13G/A - EASTMAN KODAK CO (0000031235) (Subject)
SC 13D/A - EASTMAN KODAK CO (0000031235) (Subject)
SC 13D/A - EASTMAN KODAK CO (0000031235) (Subject)